These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10344782)

  • 1. Craving for alcohol: findings from the clinic and the laboratory.
    Sinha R; O'Malley SS
    Alcohol Alcohol; 1999; 34(2):223-30. PubMed ID: 10344782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychometric properties of the Penn Alcohol Craving Scale.
    Flannery BA; Volpicelli JR; Pettinati HM
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1289-95. PubMed ID: 10470970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic approaches to the management of alcoholism.
    Anton RF
    J Clin Psychiatry; 2001; 62 Suppl 20():11-7. PubMed ID: 11584870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory-based assessment of alcohol craving in social drinkers.
    de Wit H
    Addiction; 2000 Aug; 95 Suppl 2():S165-9. PubMed ID: 11002911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alcohol availability, access to alcohol, and naltrexone on self-reported craving and patterns of drinking in response to an alcohol-cue availability procedure.
    Kruse MI; Radnovich AJ; Kalapatapu RK; Mehdiyoun N; Chambers RA; Davidson D
    J Stud Alcohol Drugs; 2012 Mar; 73(2):205-15. PubMed ID: 22333328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using naltrexone in inpatient alcoholism treatment.
    Knox PC; Donovan DM
    J Psychoactive Drugs; 1999; 31(4):373-88. PubMed ID: 10681104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.
    Drobes DJ; Anton RF; Thomas SE; Voronin K
    Alcohol Clin Exp Res; 2004 Sep; 28(9):1362-70. PubMed ID: 15365307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment.
    Rubio G; Jiménez-Arriero MA; Ponce G; Palomo T
    Alcohol Alcohol; 2001; 36(5):419-25. PubMed ID: 11524308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweet liking phenotype, alcohol craving and response to naltrexone treatment in alcohol dependence.
    Garbutt JC; Osborne M; Gallop R; Barkenbus J; Grace K; Cody M; Flannery B; Kampov-Polevoy AB
    Alcohol Alcohol; 2009; 44(3):293-300. PubMed ID: 19189996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.
    O'Malley SS; Krishnan-Sarin S; Farren C; Sinha R; Kreek MJ
    Psychopharmacology (Berl); 2002 Feb; 160(1):19-29. PubMed ID: 11862370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductions in Alcohol Craving Following Naltrexone Treatment for Heavy Drinking.
    Helstrom AW; Blow FC; Slaymaker V; Kranzler HR; Leong S; Oslin D
    Alcohol Alcohol; 2016 Sep; 51(5):562-6. PubMed ID: 27402770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Kappa Opioid Receptor Is Associated With Naltrexone-Induced Reduction of Drinking and Craving.
    de Laat B; Goldberg A; Shi J; Tetrault JM; Nabulsi N; Zheng MQ; Najafzadeh S; Gao H; Kapinos M; Ropchan J; O'Malley SS; Huang Y; Morris ED; Krishnan-Sarin S
    Biol Psychiatry; 2019 Dec; 86(11):864-871. PubMed ID: 31399255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naltrexone's effect on cue-elicited craving among alcoholics in treatment.
    Monti PM; Rohsenow DJ; Hutchison KE; Swift RM; Mueller TI; Colby SM; Brown RA; Gulliver SB; Gordon A; Abrams DB
    Alcohol Clin Exp Res; 1999 Aug; 23(8):1386-94. PubMed ID: 10470982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone: a controversial therapy for alcohol dependence.
    Freed PE; York LN
    J Psychosoc Nurs Ment Health Serv; 1997 Jul; 35(7):24-8. PubMed ID: 9243420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naltrexone in alcohol dependence.
    Hartmann PM
    Am Fam Physician; 1997 Apr; 55(5):1877-9, 1883-4. PubMed ID: 9105212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building bridges: the transdisciplinary study of craving from the animal laboratory to the lamppost.
    Monti PM; Tidey J; Czachowski CL; Grant KA; Rohsenow DJ; Sayette M; Maners N; Pierre P
    Alcohol Clin Exp Res; 2004 Feb; 28(2):279-87. PubMed ID: 15112935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.
    Hyman SM; Fox H; Hong KI; Doebrick C; Sinha R
    Exp Clin Psychopharmacol; 2007 Apr; 15(2):134-43. PubMed ID: 17469937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.
    Hendershot CS; Wardell JD; Samokhvalov AV; Rehm J
    Addict Biol; 2017 Nov; 22(6):1515-1527. PubMed ID: 27411969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.